Bangladeshi Government Working To Rid Markets Of Fake, Substandard Medicines

“Despite a backlash to its recent crackdown on the sale of counterfeit medicines in Bangladesh’s capital, Dhaka, the government has vowed to continue fighting the growing industry of illicit, substandard, counterfeit and life-endangering medicines,” IRIN reports. The article describes a September government seizure of “fake, substandard and unauthorized medicine” in the country’s medicine market and other government efforts to evaluate pharmaceutical companies and prevent such medicines from reaching the market (11/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.